[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:lichen-sclerosus-et-atrophicus":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":44,"states":45},"Lichen Sclerosus et Atrophicus",5,2,[8,16,22,30,37],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07335588","A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus",[12],"Phase 3","RECRUITING","2026-08-26T02:15:38.131683Z","2026-05-29T15:36:40.189262Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05953090","VALOR: Vaginal Atrophy & Long-term Observation of Recovery",[],"2026-08-26T02:18:09.641312Z","2026-05-05T02:43:28.872252Z",{"nct_id":23,"title":24,"phases":25,"status":27,"updated_at":28,"content_modified":29},"NCT07260825","Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial",[26],"Phase 2\u002FPhase 3","NOT_YET_RECRUITING","2026-08-26T02:17:27.435233Z","2026-05-05T02:43:28.727603Z",{"nct_id":31,"title":32,"phases":33,"status":27,"updated_at":35,"content_modified":36},"NCT07704775","Nemolizumab for LS",[34],"Phase 2","2026-08-26T02:18:48.678868Z","2026-07-19T19:36:05.087021Z",{"nct_id":38,"title":39,"phases":40,"status":41,"updated_at":42,"content_modified":43},"NCT06472765","Vaginal Ecosystem and Network in the United States Study",[],"ENROLLING_BY_INVITATION","2026-08-26T02:15:23.202838Z","2026-06-16T05:54:07.754317Z",[],[46,50],{"state":47,"count":48,"slug":49},"Ohio",3,"ohio",{"state":51,"count":48,"slug":52},"Texas","texas"]